// App-Quantinova.ai

4760 : Efficacy of EGFR/HER2 duel-kinase inhibitors in PDX models harboring known and novel HER2-mutations

Researchers

Presenter

  • Michael J. Wick

Principal Investigators

  • Monica Farley

  • Teresa Vaught

  • Justin Meade

  • Michaels Glassman

  • Alyssa Moriarty

  • Anthony W. Tolcher

  • Drew Rasco

  • Amita Patnaik

  • Kyriakos P. Papadopoulos

Medical Centers

  • START, San Antonio, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Epidermal growth factor receptor

Drug/Treatment

  • Trastuzumab

  • Neratinib

  • Lapatinib

  • Afatinib

  • Trastuzumab emtansine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved